跳至主要内容
临床试验/ChiCTR1900022012
ChiCTR1900022012尚未招募Unknown

Develop and evaluate breathhold black blood magnetic resonance imaging technology for simultaneous acquisition of quantitative T1rho and its composite metric for early diagnosis of liver fibrosis

The Research Grants Council1 个研究点 分布在 1 个国家开始时间: 2018年1月1日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
试验地点
1
主要终点
diagnostic value of the proposed MR imaging technology for detecting early stage liver fibrosis

研究概览

简要总结

To develop MRI technology as a reliable means of detecting early stage liver fibrosis

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 55(—)
性别
All

入选标准

  • Between aged 18 to 55 years; Informed written consent obtained.

排除标准

  • Contraindications to MRI such as the presence of metallic implants, claustrophobia and pregnancy

结局指标

主要结局

diagnostic value of the proposed MR imaging technology for detecting early stage liver fibrosis

次要结局

  • feasibility of this pulse sequence for routine clinical use

研究者

发起方
The Research Grants Council

研究点 (1)

Loading locations...

相似试验

Develop and evaluate breathhold black blood magnetic... | 临床试验